98768671 - HERMES

Information

  • Trademark
  • 98768671
  • Serial Number
    98768671
  • Filing Date
    September 25, 2024
    a year ago
  • Transaction Date
    June 19, 2025
    8 months ago
  • Status Date
    June 18, 2025
    8 months ago
  • Location Date
    June 18, 2025
    8 months ago
  • Status Code
    641
  • Current Location
    TMEG LAW OFFICE 106
    Employee Name
    PATEL, SAMIR
  • Attorney Docket Number
    520389.00008
    Attorney Name
    Andrew J. Avsec
    Law Office Assigned Location Code
    L60
  • Owners
Mark Drawing Code
4
Mark Identification
HERMES
Case File Statements
  • GS0091: Scientific and laboratory apparatus, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acid research; apparatus, equipment and instruments for the detection and analysis of nucleic acids; kits containing apparatus, devices, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acids research; computer software applications, downloadable; material testing instruments and machines; testing apparatus not for medical purposes; diagnostic apparatus, not for medical purposes; chemistry apparatus and instruments; DNA chips; surveying apparatus and instruments; laboratory bioreactors; genetic testing apparatus for scientific use; laboratory apparatus for detecting genetic sequences; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
  • GS0051: Chemicals for use in medical laboratories and/or for medical diagnostic purposes; therapeutic and diagnostic preparations and reagents for use in medical laboratories and/or for medical diagnostic purposes; biochemical, biological, biotechnological reagents, preparations and substances for use in medical laboratories and/or for medical diagnostic purposes; vaccine preparations; proteins for use in recombinant DNA technology for use in medical laboratories and/or for medical diagnostic purposes; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
  • GS0011: Chemical, biochemical, biological, biotechnological reagents, preparations and substances for laboratory use in the fields of life science, biotechnology and genomics; diagnostic and laboratory reagents, preparations and substances, for scientific use in the fields of life science, biotechnology and genomics; enzyme preparations for industrial purposes; enzymes for industrial purposes; industrial chemicals; biochemical catalysts; diagnostic preparations, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes; proteins for use in recombinant DNA technology, other than for medical use; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
  • GS0421: Laboratory research services in the fields of life science, biotechnology and genomics; scientific research services in the fields of life science, biotechnology and genomics; biological, biotechnological, chemical and biochemical research, analysis and development services in the fields of life science, biotechnology and genomics; contract research services in the fields of life science, biotechnology and genomics; nucleic acids discovery, analysis and research and development services; nucleic acids and genomics research and development services for drugs and pharmaceutical discovery and research; nucleic acids production, processing and purification services; consultancy services relating to nucleic acids and genomics; research services for nucleic acids for therapeutic or diagnostic use; purification and production of nucleic acids for therapeutic or diagnostic use; design and manufacture of synthetic DNA, genes and oligonucleotides for others; genetic research; research and development services in the field of genomics; research and development services relating to vaccines and medicines; providing access to a proprietary technology platform containing non-viral nanoparticles; all of the aforesaid only to be used in connection to the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
Case File Event Statements
  • 9/25/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/6/2025 - 11 months ago
    6 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 3/6/2025 - 11 months ago
    3 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 3/6/2025 - 11 months ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 3/31/2025 - 10 months ago
    4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/1/2025 - 10 months ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/18/2025 - 8 months ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/18/2025 - 8 months ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/18/2025 - 8 months ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT